Literature DB >> 15561137

Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 A.

Matthew S Kelker1, Erik W Debler, Ian A Wilson.   

Abstract

Triggering receptor expressed on myeloid cells (TREM) 1 is an activating receptor expressed on myeloid cells whose ligand(s) remain elusive. TREM-1 stimulation activates neutrophils and monocytes and induces the secretion of pro-inflammatory molecules, which amplifies the Toll-like receptor-initiated responses to invading pathogens. In addition, TREM-1 mediates the septic shock pathway, and thus represents a potential therapeutic target. We report the crystal structure of the mouse TREM-1 extracellular domain at 1.76A resolution. The mouse extracellular domain is monomeric, consistent with our previous human TREM-1 structure, and strongly supports the contention that the globular TREM-1 head is a monomer contrary to proposals of a symmetric dimer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561137     DOI: 10.1016/j.jmb.2004.10.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Preparation, crystallization, and preliminary crystallographic analysis of wild-type and mutant human TREM-2 ectodomains linked to neurodegenerative and inflammatory diseases.

Authors:  Daniel L Kober; Kelsey M Wanhainen; Britney M Johnson; David T Randolph; Michael J Holtzman; Tom J Brett
Journal:  Protein Expr Purif       Date:  2014-02-07       Impact factor: 1.650

2.  Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Authors:  Marc Derive; Frédéric Massin; Sébastien Gibot
Journal:  Self Nonself       Date:  2010-07-02

3.  Efficient Mammalian Cell Expression and Single-step Purification of Extracellular Glycoproteins for Crystallization.

Authors:  Daniel L Kober; Zeynep Yurtsever; Thomas J Brett
Journal:  J Vis Exp       Date:  2015-12-23       Impact factor: 1.355

Review 4.  The structural basis of ligand recognition by natural killer cell receptors.

Authors:  M Gordon Joyce; Peter D Sun
Journal:  J Biomed Biotechnol       Date:  2011-05-18

Review 5.  Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis.

Authors:  Sébastien Gibot
Journal:  Crit Care       Date:  2005-06-03       Impact factor: 9.097

Review 6.  Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

Authors:  Kelsey Roe; Sébastien Gibot; Saguna Verma
Journal:  Front Microbiol       Date:  2014-11-26       Impact factor: 5.640

7.  Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms.

Authors:  Daniel L Kober; Jennifer M Alexander-Brett; Celeste M Karch; Carlos Cruchaga; Marco Colonna; Michael J Holtzman; Thomas J Brett
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

Review 8.  Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1).

Authors:  Federica Raggi; Maria Carla Bosco
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

Review 9.  Function of TREM1 and TREM2 in Liver-Related Diseases.

Authors:  Huifang Sun; Jianguo Feng; Liling Tang
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.